Novo Nordisk and Aspect Biosystems have entered a new phase of their collaboration aimed at developing curative cell-based medicines for... Read more
Tag: #Global Trends
CDC Official Downplays Potential Loss of U.S. Measles Elimination Status
Amid expanding measles outbreaks across several states, a top official at the Centers for Disease Control and Prevention (CDC) suggested... Read more
Corvus Shares Surge on Positive Data for Oral Eczema Treatment
On January 20, 2026, Corvus Pharmaceuticals saw its stock price nearly triple following the release of Phase 1 clinical trial... Read more
Johnson & Johnson Eyes $100B Sales Milestone Amid Patent Pressures
In its financial report released January 21, 2026, Johnson & Johnson (J&J) set an ambitious target for the upcoming year,... Read more
Novavax Enters $530 Million Licensing Agreement with Pfizer
Novavax and Pfizer have announced a non-exclusive licensing agreement, marking a pivotal strategic shift for Novavax in 2026. Under the... Read more
Pfizer CEO evaluates the current state of U.S. vaccine policy
During a World Economic Forum event in Davos, Switzerland, Pfizer CEO Albert Bourla offered candid insights into the current healthcare... Read more
President Trump reverses tariff threats against European allies
Just days after issuing a stern warning to impose new tariffs on eight European nations, President Donald Trump has officially... Read more
Legal turning point in Johnson & Johnson talc litigation in the U.S.
A court-appointed special master in New Jersey has recommended that plaintiffs be allowed to present expert witness testimony in the... Read more
Pink on the Square – A symbol of solidarity and survival at JPM 2026
Amid the traditional sea of navy and gray at the J.P. Morgan Healthcare Conference in San Francisco, flashes of pink... Read more









